Research Article
FCGR2A Promoter Methylation and Risks for Intravenous Immunoglobulin Treatment Responses in Kawasaki Disease
Table 4
Possible transcription factor binding sites identified by JASPAR.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
The corresponding CpG sites reached the statistical significance in Table 2 or Table 3. Accession number is the NCBI protein accession number. bThe relative score is provided by the JASPAR according to the similarity of motif sequence. cThe sequence in our study is listed as follows: TGCAAGCTCTGCCTCCCGAGGTTCACGBCCATTCTCCTGCCTCAGCCTCCCGCAGTAGCTGGGACTATCTGCCACCGDCGECCCGF GCTAAATTTTTTTTGTATTATTAGTAGAGACGGGGGTTTCACCGHTGTTAGCCAGGATGGTCTCGIATCTCCTGACCTCGJ TGATCCACCCGKCCTTGGCCTCCCAAAG. The sites marked as A–K are the methylation loci. |